跳至主要内容
临床试验/NCT02790281
NCT02790281已完成不适用

A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

Ferring Pharmaceuticals2 个研究点 分布在 2 个国家目标入组 33 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
2
主要终点
Exploratory: Levels of IL-6

研究概览

简要总结

The purpose of this study is to measure IL-6 and IL-6/sIL-6R complex levels in subjects with active moderate to severe ulcerative colitis or Crohn's disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects diagnosed with active moderate to severe ulcerative colitis (*partial Mayo ≥ 5) or Crohn's disease (Harvey & Bradshaw ≥ 8) *partial Mayo: 9-point scale that excludes the endoscopic components of the Mayo score

排除标准

  • Presence of another inflammatory disease, except for mild cutaneous psoriasis
  • Concomitant gastrointestinal infection or otherwise serious infection including Crohn's disease infectious complication
  • Treatment with Infliximab, Adalimumab, Certolizumab Pegol or other immune-modulating biologics within 8 weeks prior to the visit
  • Having a known or suspected gastrointestinal or otherwise serious infection within 8 weeks prior to the visit
  • Concomitant diagnosed or suspected malignant disease

结局指标

主要结局

Exploratory: Levels of IL-6

时间窗: At Day 1

Blood sample was taken for analysis of levels of IL-6.

Exploratory: Levels of C-reactive Protein (CRP)

时间窗: At Day 1

Blood sample was taken for analysis of levels of CRP.

Exploratory: Levels of IL-6/sIL-6R Complex

时间窗: At Day 1

Blood sample was taken for analysis of levels of IL-6/sIL6-R complex.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Study to Investigate Interleukin-6 (IL-6) and... | 临床试验